Funded Projects › FP7
INTENSO · Gaining Productivity, Cost Efficiency and Sustainability in the Downstreaming Processing of Bio Products by novel Integration and Intensification strategies
The European Life science and chemical industries increasingly depend on effi-cient, sustainable, and cost-effective bioprocessing platforms to remain competi-tive. A critical assessment of current bottlenecks during (bio) manufacturing clearly indicates that the recovery and purification of biologicals in large scale in responsible for many inefficiencies.INTENSO proposes an evaluation of the current situation of the downstream processing scenario with the aim of identifying inefficiencies and concomitantly introduce a debottlenecking overarching strategy. The later will be build up on the basis of a multidisciplinary approach, which considers opportunities to im-prove the process technology and underlying chemistry / biology and materials science at the same time. INTENSO will work alongside 4 technological axes, targeting promising and up-coming technologies and tailoring such technologies to the manufacturing of various classes of (bio) products. Intensification of individual unit operations and global process integration, as well as, dovetailing with fermentation / cell cultivation will be employed to the mentioned end.INTENSO will target new classes of (bio) products like Monoclonal Antibodies (Mabs), pDNA (e.g. for genetic vaccination), Virus Like Particles (VLP) or nano-plexes. All the mentioned new products are part of most industrial R&D pipelines and offer an excellent opportunity to introduce innovative bioprocessing.The results of the project are expected to contribute to the understanding of current industrial downstream processing practice, to the definition and alleviation of current inefficiencies, to the development and / or implementation of novel technologies, and to more efficient / sustainable and cost effective (bio) manufacturing. Various technologies will be studied utilizing a nano-to-process strategy so as to introduce integration / intensification during bioprocessing.
Consortium · 17 organisations
CONSTRUCTOR UNIVERSITY BREMEN GGMBH
DE · €810,801
ICOSAGEN AS
EE · €274,460
ERA BIOTECH
ES · €123,460
SARTORIUS BIA SEPARATIONS, SEPARACIJSKE TEHNOLOGIJE, D.O.O.
SI · €288,596
PROXCYS
NL · €294,780
ZERA INTEIN PROTEIN SOLUTIONS SL
ES · €171,600
SOFIA UNIVERSITY ST KLIMENT OHRIDSKI
BG · €297,620
CHIPRO GMBH
DE · €317,017
ETHRIS GMBH
DE · €295,028
GENERI BIOTECH
CZ · €300,600
UNIVERSITAET FUER BODENKULTUR WIEN
AT · €402,380
UNIVERSIDAD NACIONAL DE QUILMES
AR · €218,014
BIOMEDAL SL
ES · €291,400
VIRTUALPIE LTD
UK · €392,418
DSM BIOLOGICS COMPANY BV
NL · €46,509
INSTITUTO SUPERIOR TECNICO
PT · €321,153
INFOCONSULT GESELLSCHAFT FUR INFORMATIONSTECHNIK MBH
DE · €415,123
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.